BioSpace

Opinion: FDA must ensure American patients can access new and experimental drugs

The FDA has taken important steps through Operation TrialBlazer and stronger scrutiny of foreign clinical data, but more must be done to make the United States more competitive in attracting clinical trials as China’s capabilities rise.

By BioSpace

1 min read
Opinion: FDA must ensure American patients can access new and experimental drugs
Opinion: FDA must ensure American patients can access new and experimental drugs

Got news to share with the events industry?

Submit a press release or story tip and reach thousands of event professionals.

Get in touch→

More in Health Tech

Related Insights